Table 1.
Negative SARS-CoV-2 HCWs (n = 252) | Positive SARS-CoV-2 HCWs (n = 67) | p-value | Adjusted p-value | |
---|---|---|---|---|
Male sex. n (%) | 50 (19.84) | 9 (13.43) | 0.306 | 0.638 |
Age. years. median [IQR] | 35.9 [27.5–47.0] | 36.0 [29.4–47.7] | 0.656 | 0.926 |
Body Mass Index*. n | 249 | 67 | ||
median [IQR] | 23.3 [21.1–27.1] | 24 [22.5–27.3] | 0.148 | 0.473 |
Currently smoker. n (%) | 64/252 (25.4) | 6/67 (8.96) | 0.013 | 0.091 |
Alcohol consumption*. Daily. n(%) | 8/251 (3.19) | 3/67 (4.48) | 0.248 | 0.606 |
Presence of comorbidity*. n (%) | 109/249 (43.78) | 17/66 (25.76) | 0.012 | 0.091 |
Description of comorbidity | ||||
Neurological disorders. n (%) | 7 (6.42) | 1 (5.88) | 1.000 | 1.000 |
Cardiovascular disorders. n (%) | 2 (1.83) | 1 (5.88) | 0.355 | 0.649 |
Hypertension. n (%) | 14 (12.84) | 3 (17.65) | 0.701 | 0.935 |
Heart Failure. n (%) | 3 (2.75) | 1 (5.88) | 0.444 | 0.735 |
Diabetes. n (%) | 5 (4.59) | 0 (0) | 1.000 | 1.000 |
Immune deficiency. n (%) | 2 (1.83) | 0 (0) | 1.000 | 1.000 |
Liver disease. n (%) | 2 (1.83) | 0 (0) | 1.000 | 1.000 |
Kidney disease. n (%) | 1 (0.92) | 1 (5.88) | 0.253 | 0.606 |
Cancer. n (%) | 2 (1.83) | 1 (5.88) | 0.355 | 0.649 |
Hypothyroidy. n (%) | 11 (10.09) | 2 (11.76) | 0.688 | 0.935 |
Rheumatic disease. n (%) | 2 (1.83) | 2 (11.76) | 0.088 | 0.324 |
Chronic respiratory disease. n (%) | 25 (22.94) | 1 (5.88) | 0.193 | 0.580 |
HCW in contact with patients. n (%) | 228/252 (90.48) | 64/67 (95.52) | 0.284 | 0.634 |
Delay from symptoms to screening. day. median [IQR] | 5 [3–8] | 3 [2–6] | 0.015 | 0.091 |
Symptom | ||||
Fever. n (%) | 149/252 (59.13) | 45/67 (67.16) | 0.291 | 0.634 |
Sore throat*. n (%) | 55/250 (22) | 12/67 (17.91) | 0.576 | 0.837 |
Diarrheas. n (%) | 104/252 (41.27) | 16/67 (23.88) | 0.014 | 0.091 |
Pain. n (%) | 187/252 (74.21) | 53/67 (79.1) | 0.505 | 0.758 |
Muscular. n (%) | 155 (82.89) | 50 (94.34) | 0.062 | 0.249 |
Chest. n (%) | 38 (20.32) | 11 (20.75) | 1.000 | 1.000 |
Joints. n (%) | 24 (12.83) | 3 (5.66) | 0.225 | 0.601 |
Abdominal. n (%) | 72 (38.5) | 12 (22.64) | 0.048 | 0.232 |
Asthenia*. n (%) | 204/250 (81.6) | 56/67 (83.58) | 0.845 | 1.000 |
Rhinorrhea *. n (%) | 121/250 (48.4) | 46/67 (68.66) | 0.005 | 0.079 |
Nauseas*. n (%) | 68/249 (27.31) | 14/67 (20.9) | 0.365 | 0.649 |
Cough. n (%) | 135 (53.57) | 47 (70.15) | 0.022 | 0.115 |
Shortness of breath*. n (%) | 96/249 (38.55) | 21/67 (31.34) | 0.346 | 0.649 |
Headaches. n (%) | 198 (78.57) | 54 (80.6) | 0.847 | 1.000 |
Irritability*. n (%) | 65/250 (26) | 14/67 (20.9) | 0.485 | 0.758 |
Anosmia. n (%) | 24 (9.52) | 26 (38.81) | < 0.001 | < 0.001 |
Ageusia. n (%) | 27 (10.71) | 25 (37.31) | < 0.001 | < 0.001 |
Ophthalmic pain. n (%) | 28 (11.11) | 6 (8.96) | 0.775 | 0.979 |
Hospitalized. n (%) | 0/252 (0) | 2/67 (2.98) | 0.043 | 0.187 |
*Missing data.